Camzyos

Camzyos is a medicine used in adults to treat obstructive hypertrophic cardiomyopathy (oHCM), a disease in which the muscle in the main pumping chamber of the heart becomes thickened or enlarged, which can block the flow of blood from the heart to the rest of the body. It is used in adults who have symptoms of the disease (class II or class III oHCM). The ‘class’ reflects the seriousness of the disease: ‘class II’ involves slight limitation of physical activity and ‘class III’ involves marked limitation of physical activity. Camzyos contains the active substance mavacamten.